## **Core Concept**
The Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is a condition characterized by excessive release of antidiuretic hormone (ADH), also known as vasopressin, leading to water retention and hyponatremia. Various drugs can induce SIADH by stimulating ADH release or mimicking its action.

## **Why the Correct Answer is Right**
The correct answer, . **Cyclophosphamide**, is associated with SIADH because it can cause inappropriate ADH secretion. This is a well-documented side effect, particularly relevant in the context of chemotherapy. The mechanism might involve direct stimulation of ADH release or an effect on the hypothalamus.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While certain **Lithium** effects can lead to nephrogenic diabetes insipidus (a condition opposite to SIADH), it is not commonly associated with SIADH.
- **Option B:** **Diazoxide** is used to treat hypoglycemia and works by inhibiting insulin release; it is not commonly linked with SIADH.
- **Option D:** **Glibenclamide** (Glyburide) is a sulfonylurea used in diabetes management and does not have a well-established link with SIADH.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that **SIADH can be caused by various drugs**, including certain chemotherapeutic agents like **Cyclophosphamide**, making it essential to monitor electrolytes closely in patients on these medications. Classic causes include **Oxytocin**, **Vasopressin analogues**, and **Cyclophosphamide**.

## **Correct Answer:** . **Cyclophosphamide**